The pandemic accelerated the structural growth story in the healthcare sector that was already underway. The global pharmaceutical manufacturing market size is expected to grow at a compound annual growth rate of more than 11% from 2021 to 2028, according to Grandview Research. Our latest pick in our Best Health Care Dividend Stocks List is probably going to be one of the biggest beneficiaries of the secular trend in the pharmaceutical industry.
Our pick is a well-respected leading pharmaceutical company, which discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Established in the 1890s, it has created a strong moat around the drug development process, which cannot be easily replicated by competition. To provide perspective, our pick has one of the largest drug development pipelines amongst top U.S. pharma companies.
Our pick is on the verge of getting approvals for three drugs over the next 12 months, which are expected to be game-changers in their respective segments. It is time to hurry, as our pick, which has 15+ consecutive years of dividend increase history, is going ex-dividend on Thursday, March 31.
You can check out the Best Health Care Dividend Stocks List to explore all the stocks.
